Goldman Sachs Group INC Schedule 13G passive stakes

The Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a 5.8% beneficial ownership stake in South Bow Corporation.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC reported a 0.0% beneficial ownership stake in Nevro Corp. common stock as of June 30, 2025.

The Goldman Sachs Group and its affiliate have reported a 4.9% beneficial ownership stake in KORE Group Holdings, Inc. common stock.

Goldman Sachs Group and its affiliate have reported a 6.5% beneficial ownership stake in Syndax Pharmaceuticals, Inc., holding over 5.5 million common shares.

The Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have reported a 7.8% beneficial ownership stake in Indivior PLC, totaling 9,789,169 ordinary shares.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a 6.4% beneficial ownership stake in Allied Gold Corporation, totaling 7,524,024 common shares.

The Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a 5.6% beneficial ownership stake in SpringWorks Therapeutics, Inc.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, indicating they no longer hold beneficial ownership in Chimerix, Inc.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC report 0% beneficial ownership in Black Spade Acquisition II Co., indicating a full divestment or reduction below reporting thresholds.

Goldman Sachs Group and its affiliate reported a negligible 0.0% beneficial ownership in Accolade, Inc. common stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 7.9% in Silverbox Corp IV's Class A ordinary shares.

The Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 8.9% in Fortrea Holdings Inc.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a passive 5.2% beneficial ownership stake in Foot Locker, Inc., totaling 4,963,086.90 shares.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a 0.0% beneficial ownership stake in 2SEVENTY BIO, INC. as of June 30, 2025.

Goldman Sachs Group and its affiliate updated their beneficial ownership in Cross Country Healthcare, Inc., reporting a 5.8% stake.

The Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 0.7% in Astronics Corporation.

Goldman Sachs Group and Goldman Sachs & Co. LLC report a 3.1% beneficial ownership stake in NRG Energy as of June 30, 2025.

The Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a 5.3% beneficial ownership stake in ICAD, Inc. common stock.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have reported a 7.6% beneficial ownership stake in Avis Budget Group, Inc.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have disclosed a passive beneficial ownership of 5.4% in Amedisys, Inc. common stock.

Goldman Sachs Group and its subsidiary have disclosed a 5.1% beneficial ownership stake in TC Energy Corporation, holding over 53 million common shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a 5.2% beneficial ownership stake in Redfin Corporation's common stock.

Goldman Sachs Group and its affiliate have reported a 4.1% beneficial ownership stake in Oaktree Acquisition Corp. III Life Sciences.

Goldman Sachs Group and its affiliate Goldman Sachs & Co. LLC have disclosed a 6.0% passive beneficial ownership stake in Distoken Acquisition Corporation.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a 6.4% beneficial ownership stake in Centurion Acquisition Corp.'s Class A ordinary shares.

The Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have reported a 5.4% beneficial ownership stake in Bitcoin Depot Inc.'s Class A Common Stock.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a 3.1% passive beneficial ownership stake in Chenghe Acquisition II Co.'s Class A ordinary shares.

Goldman Sachs Group and its affiliate have reported a 10.8% beneficial ownership stake in VAST Renewables Limited, held for ordinary business purposes.

The Goldman Sachs Group, Inc. and its affiliate Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 5.1% in Taysha Gene Therapies, Inc., totaling 12,748,968 shares of common stock.

The Goldman Sachs Group, Inc. and its affiliate Goldman Sachs & Co. LLC have jointly disclosed a passive beneficial ownership of 5.1% in Bilibili, Inc.'s American depositary shares.